Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antibody response induction is the process by which the immune system detects an antigen (such as a pathogen, vaccine, or therapeutic biologic) and activates B cells to produce antigen-specific antibodies. This involves either T cell-dependent or T cell-independent pathways that result in the proliferation of antibody-secreting plasma cells, isotype switching, and often the generation of memory B cells. The process underpins humoral immunity and is essential for protection against infections and the action of many vaccines and therapeutic antibodies. However, undesirable antibody responses (immunogenicity) to biologics can reduce efficacy and pose safety risks, including hypersensitivity and immune complex diseases. This process is not a specific molecular target but rather a key phenomenon manipulated in vaccine and immunotherapy development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antibody response induction.